TIDMAMS
RNS Number : 5200L
Advanced Medical Solutions Grp PLC
13 May 2022
13 May 2022
Advanced Medical Solutions Group plc
("AMS", the "Company" or the "Group")
Director/PDMR Shareholding
Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS),
the world-leading specialist in tissue-healing technologies ,
announces the following PDMR share transactions.
The Company was notified on 10 May 2022 that following his
decision to participate in the Deferred Share Bonus (DSB), Chris
Meredith, who is a Director and PDMR, undertook the following
transactions:
-- The exercise of 395,355 options from the Long-Term Incentive Plan (LTIP).
-- The exercise of 34,608 options from the existing Deferred Annual Bonus Plan (DAB).
-- Elected to receive an additional 543 dividend shares which
were earned during the holding period under the terms of the
DAB.
-- T he exercise of 23,415 Ordinary Shares of 5p from the
existing DSB and the award of 56,785 shares under the DSB.
-- The sale of 246,384 Ordinary Shares of 5p each on 10 May 2022
at a share price of 271.5p per Ordinary Share by way of an
off-market sale. The proceeds from the sale of the shares was used
to purchase shares in the DSB and cover the tax payable on the
above exercises.
The Trust which manages the Deferred Share Bonus Plan ("DSB") on
behalf of the employees of AMS purchased ordinary shares of 5 pence
each ("Ordinary Shares") between 10 and 12 May 2022, at an average
price of 270.5p on behalf of Chris Meredith as part of the DSB and,
under the terms of the DSB, these shares will be held in trust on
his behalf.
As a result of these transactions Chris Meredith's beneficial
interest in the Company increased and his overall holding is as
follows:
PDMR No. of DSBs No. of DABs No. of LTIPs Resultant holding % of issued
after exercise after exercise after exercise of Ordinary share capital
Shares
Chris Meredith 117,709 6,219 877,145 1,760,162 0.82%
---------------- ---------------- ---------------- ------------------ ---------------
The Company was also notified on 12 May 2022 that following the
decision by Eddie Johnson, who is a Director and PDMR, to
participate in the DSB t he Trust which manages the Deferred Share
Bonus Plan ("DSB") on behalf of the employees of AMS purchased
ordinary shares of 5 pence each ("Ordinary Shares") between 10 and
12 May 2022, at an average price of 270.5p on behalf of Eddie
Johnson as part of the DSB and, under the terms of the DSB, these
shares will be held in trust on his behalf. Eddie Johnson was
awarded of 17,225 shares under the DSB.
As a result of these transactions Eddie Johnson's beneficial
interest in the Company increased and his overall holding is as
follows:
PDMR No. of DSBs No. of DABs No. of LTIPs Resultant holding % of issued
after exercise held held of Ordinary share capital
Shares
Eddie Johnson 110,140 12,737 348,258 84,309 0.04%
---------------- ------------ ------------- ------------------ ---------------
The notification below, made in accordance with the requirements
of the EU Market Abuse Regulation, provides further detail.
Notification and public disclosure of transactions by persons
discharging managerial responsibilities and persons closely
associated with them
1. Details of the person discharging managerial responsibilities/person
closely associated
a) Name: Chris Meredith
---------------------------------------------------------------------
2. Reason for the notification
---------------------------------------------------------------------
a) Position/status: Director/PDMR
---------------------------------------------------------------------
b) Initial notification/Amendment: Initial Notification
---------------------------------------------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
---------------------------------------------------------------------
a) Name: Advanced Medical Solutions Group plc
---------------------------------------------------------------------
b) LEI: 213800HJP6OWOSZI1L74
---------------------------------------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
---------------------------------------------------------------------
a) Description of the financial instrument, type of instrument:
Ordinary Shares of 5p
Identification code: GB0004536594
---------------------------------------------------------------------
b) Nature of the transactions:
* Exercise of 23,415 shares from the Deferred Share
Bonus Plan
* Exercise of 34,608 shares from the Deferred Annual
Bonus Plan
* Award of 543 Dividend Shares from the Deferred Annual
Bonus Plan
* Exercise of 395,355 shares from the Long-Term
Incentive Plan
* Sale of 246,384 shares
* Purchase of 28,725 shares through the Deferred Share
Bonus Plan
* Award of 56,785 shares in the Deferred Share Bonus
Plan
---------------------------------------------------------------------
c) Price(s) and volume(s):
Sale of shares: Price(s) Volume(s)
GBP2.715 246,384
----------
---------------------------------------------------------------------
d) Aggregated information: (Relates to those shares sold
only)
Aggregated volume: 246,384
Aggregated price: GBP2.715
---------------------------------------------------------------------
e) Date of the transaction: 10/05/2022
---------------------------------------------------------------------
f) Place of the transaction: London Stock Exchange, AIM
Market (XLON)
---------------------------------------------------------------------
1. Details of the person discharging managerial responsibilities/person
closely associated
a) Name: Eddie Johnson
---------------------------------------------------------------------
2. Reason for the notification
---------------------------------------------------------------------
a) Position/status: Director/PDMR
---------------------------------------------------------------------
b) Initial notification/Amendment: Initial Notification
---------------------------------------------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
---------------------------------------------------------------------
a) Name: Advanced Medical Solutions Group plc
---------------------------------------------------------------------
b) LEI: 213800HJP6OWOSZI1L74
---------------------------------------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
---------------------------------------------------------------------
a) Description of the financial instrument, type of instrument:
Ordinary Shares of 5p
Identification code: GB0004536594
---------------------------------------------------------------------
b) Nature of the transaction:
* Purchase of 8,945 shares through the Deferred Share
Bonus Plan
* Award of 17,225 shares in the Deferred Share Bonus
Plan
---------------------------------------------------------------------
c) Price(s) and volume(s):
Sale of shares: Nil
---------------------------------------------------------------------
d) Aggregated information: (Relates to those shares sold
only)
Aggregated volume:
Aggregated price:
---------------------------------------------------------------------
e) Date of the transaction: 10/05/2022
---------------------------------------------------------------------
f) Place of the transaction: London Stock Exchange, AIM
Market (XLON)
---------------------------------------------------------------------
-End -
For further information, please visit www.admedsol.com or
contact:
Advanced Medical Solutions Group plc Tel: +44 (0) 1606
545508
Chris Meredith, Chief Executive Officer
Eddie Johnson, Chief Financial Officer
Consilium Strategic Communications Tel: +44 (0) 20 3709
5700
Mary-Jane Elliott / Matthew Neal / Matthew AMS@consilium-comms.com
Cole
Investec Bank PLC (NOMAD & Broker) Tel: +44 (0) 20 7597
5970
Daniel Adams / Gary Clarence
HSBC Bank PLC (Broker) Tel: 44 (0) 20 7991
8888
Sam McLennan / Joe Weaving / Stephanie
Cornish
About Advanced Medical Solutions Group plc - see
www.admedsol.com
AMS is a world-leading independent developer and manufacturer of
innovative tissue-healing technology, focused on quality outcomes
for patients and value for payers. AMS has a wide range of surgical
products including tissue adhesives, sutures, haemostats, internal
fixation devices and internal sealants, which it markets under its
brands LiquiBand(R) , RESORBA(R) , LiquiBandFix8(R) and Seal-G(R) .
AMS also supplies wound care dressings such as silver alginates,
alginates and foams through its ActivHeal(R) brand as well as under
white label. Since 2019, the Group has made three acquisitions:
Sealantis, an Israeli medical device company with a
patent-protected sealant technology platform; Biomatlante, an
established French developer and manufacturer of innovative
surgical biomaterial technologies and Raleigh, a UK leading coater
and converter of materials predominately for woundcare and
bio-diagnostics products.
AMS's products, manufactured in the UK, Germany, France, the
Netherlands, the Czech Republic and Israel, are sold globally via a
network of multinational or regional partners and distributors, as
well as via AMS's own direct sales forces in the UK, Germany, the
Czech Republic and Russia. The Group has R&D innovation hubs in
the UK, Germany, France and Israel. Established in 1991, the Group
has more than 700 employees. For more information, please see
www.admedsol.com .
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHDXLFFLELBBBQ
(END) Dow Jones Newswires
May 13, 2022 13:08 ET (17:08 GMT)
Advanced Medical Solutions (AQSE:AMS.GB)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Advanced Medical Solutions (AQSE:AMS.GB)
Gráfica de Acción Histórica
De May 2023 a May 2024
